FHI 360 is a leading international nonprofit human development organization dedicated to improving lives through integrated, locally driven solutions. It operates in more than 60 countries and all U.S. states, specializing in health, education, nutrition, and economic development. In the pharmaceutical and biotech sectors, FHI 360 acts as a major research organization and clinical trial manager. It leads several global research networks, including the HIV Prevention Trials Network (HPTN) and the Microbicide Trials Network (MTN). The organization is a primary partner for the NIH and USAID, frequently managing large-scale Phase I-IV clinical trials in resource-limited settings.
CLASSIFICATION
Company Type:CRO
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Global Health Research & CRO
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$820M-$870M
Founded:1971
Ownership:nonprofit
Status:operating
FUNDING
Investors:USAID, Bill & Melinda Gates Foundation, National Institutes of Health (NIH), U.S. State Department, Global Fund
PIPELINE
Stage:Phase 3
Lead Drug Stage:Phase 3 (6-month injectable DMPA)
Modalities:Small molecule, Drug-delivery implants, Injectables, Microneedle patches
Active Trials:45
Trial Phases:Phase 1: 12 | Phase 2: 15 | Phase 3: 8 | Phase 4: 10
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:FHI Clinical, FHI Solutions, FHI Ventures, FHI Partners
Key Partnerships:USAID (Primary funding partner), Bill & Melinda Gates Foundation (Contraceptive innovation), NIH (HIV prevention networks), Johnson & Johnson (Global health initiatives)
COMPETITION
Position:Leader
Competitors:RTI International, PATH, Population Council, CARE, Save the Children
LEADERSHIP
Key Executives:
Tessie San Martin - CEO
Kavita Nanda - Director of Medical Research
Scientific Founders:Elton Kessel
Board Members:Edward W. (Ned) Greeley, Philomena G. Gwanmesia
LINKS
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of FHI 360 and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with FHI 360. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.